CME for Physicians, Nurses & More| Continuing Medical Education Credit

Education

Search

Saved Activities

0 Activities

0 Activities

Filter Content

Page 3 of 9

Results 151 - 225 of 606

9157-0003-slide263x149

NTM-LD Daignosis and Management - Slide Deck

Emerging Nonfactor Approaches for Patients with Hemophilia

Identification of Relapsed ALL

ILD Patient Case Library: IPF, PF-ILD, SSc-ILD, and Post COVID-19

9089_nsclc_titleslide

TARGET for NSCLC: Genomic Pathways and Use of EGFR Therapies

PAH: Risk Reduction Strategies Using Single and Combination Therapies

Ensuring Effective Care Transitions in Beta Thalassemia

9102-chest-slides

IPF Management and Antifibrotic Therapy - Slide Deck

9088-covid-slides

Post COVID-19 and Patients With and Without Pre-existing ILD - Slide Deck

9088-ipf-slides

A Collaborative Approach to IPF Management - Slide Deck

9088-sscild-slides

Practical Solutions to SSc-ILD Treatment - Slide Deck

Improved Patient Outcomes in PAH

9088-pfild-slides8

A New Paradigm in Treating ILD - Slide Deck

Principles of Management of Chronic GVHD

Diagnosing and Assessing Chronic Graft-versus-Host Disease

IPF Management and Antifibrotic Therapy

How to Develop an Effective Risk Reduction Strategy in Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension (PAH) - Therapy Options Explained

Updates in Duchenne Muscular Dystrophy: A Focus on Emerging Gene Therapy

EXPLORE Learning Experience: COVID-19 and Monoclonal Antibodies

EXPLORE Learning Experience: Understanding and Managing NTM-Lung Disease

Cardiac Amyloidosis: Is It A Zebra or A Horse? Webinar Summary Module

Cardiac Amyloidosis Webinar #4: Treatment of Cardiac Amyloidosis

Cardiac Amyloidosis Webinar #3: Establishing the Correct Diagnosis

Cardiac Amyloidosis Webinar #2: Cardiac Imaging Pearls

Cardiac Amyloidosis Webinar #1: Who Should I be Testing?

Updates in Diabetes Care for Primary Care Providers

Osteoporosis Updates: Primary Care’s Critical Role

Primary Care and Dyslipidemia: What Should You Do?

Staying Current in Obesity Management: Key Updates for Primary Care

Thyroid Assessment: Updates for Primary Care

A New Paradigm in Treating ILD

A Collaborative Approach to IPF Management

Practical Solutions to SSc-ILD Treatment

Post COVID-19 and Patients With and Without Pre-existing ILD

Exploring CGM: Achieving Treatment Goals Together

Reversing DOACS: Providing Answers to What, Where and How

How to Choose the Right Therapy for Your Patients with IPF

PAH: Aligning Treatment Strategy to Risk Level

PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes

LGMD: Mutation-specific Nomenclature

LGMD Symptomatology

LGMD Mutations and Disease Types

Tests and Outcomes - DMD

Genes, Exons, and the Pathophysiology of DMD

The Natural History of DMD

Reversing DOACS: Recording from Live Session held on July 18, 2021

Conquer the Clot: Addressing VTE in Your Patients with Cancer

Patient Develops de novo Features of ILD After a COVID Infection

SSc-ILD Individualized Treatment

Overlapping Symptoms and Risk Factors for COVID and IPF

Multidisciplinary Management of IPF

Fundamentals of Diagnosis: SSc-ILD

Fundamentals of Diagnosis: PF-ILD

Updates in SMA: Cure SMA Conference Coverage (CME/CE)

9076-0001-263x149

Healthcare Disparities in African Americans With Myeloma

Beyond The Basics Of PAH

Pediatric GHD: Working Together To Ensure Success

New and Emerging Options for the Management of MS

Perioperative Nutrition and Wound Healing

Special Considerations for Nutrition for the Elderly

Diabetes & Nutrition

Comorbidities and Selection of DMTs

Itching for Relief: Atopic Dermatitis Management Considerations for PAs and NPs

IPF Management in Practice: A Truly Interactive Experience

Conference Coverage on DMD and LGMD: Latest Developments

Management of Breakthrough Disease Activity in MS

Key Considerations: Advances in Gene Therapy for Hemophilia

Highlights From the EAHAD 2021 Virtual Congress

Updated Follow-up of the Alta Study, Giroctocogene Fitelparvovec (SB-525)

First Data From the Phase 3 HOPE-B Gene Therapy Trial

The World Federation of Hemophilia Gene Therapy Registry

Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Pipe)

AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Leebeek)

AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Miesbach)

Page 3 of 9